ELV Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.…
Industry Peers
Healthcare PlansKey Statistics
About Elevance Health (NYSE: ELV)
›
Elevance Health (NYSE: ELV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Healthcare Plans industry, part of the Healthcare sector, and reports about 96,129 employees.
The shares were at 390.16 USD on 19 November 2026, up 21.1% over 52 weeks. Its 52-week range is 274.84 USD to 450.69 USD: the price is 13.4% below the high and 42.0% above the low.
At a market capitalisation of 84.30B USD, it trades at 16.6 times trailing earnings and 12.9 times forward earnings. The median trailing P/E of its 9 largest Healthcare Plans peers is 22.5, a discount of 26% for ELV. It pays a dividend yielding 1.72% (it pays out 29% of its earnings), against a median of 2.42% among the dividend payers in that peer group.
Elevance Health reports return on equity of 12.9%, an operating margin of 4.0% and revenue up 1.4% year over year.
It holds more cash than debt, a net cash position of 7.09B USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 482.38 USD is 23.6% above the current price. The next earnings report is expected on 28 January 2027.